A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis2018-01-17T17:00:50-05:00
Natural History of Multiple Sclerosis with Childhood Onset Natural History of Multiple Sclerosis with Childhood Onset2018-01-17T17:00:50-05:00
Scientists Probe Role of Vitamin D: Deficiency a Significant Problem, Experts Say Scientists Probe Role of Vitamin D: Deficiency a Significant Problem, Experts Say2018-01-17T17:00:50-05:00
Infections and the risk of relapse in multiple sclerosis Infections and the risk of relapse in multiple sclerosis2018-01-17T17:00:50-05:00
Sex, MHC and complement C4 in autoimmune diseases Sex, MHC and complement C4 in autoimmune diseases2018-01-17T17:00:45-05:00
Sunlight, Vitamin D and Multiple Sclerosis Sunlight, Vitamin D and Multiple Sclerosis2018-01-17T17:00:45-05:00
The immunological functions of the vitamin D endocrine system The immunological functions of the vitamin D endocrine system2018-01-17T17:00:45-05:00
The immunological functions of the vitamin D endocrine system The immunological functions of the vitamin D endocrine system2018-01-17T17:00:45-05:00
Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in 3 the immune system Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in 3 the immune system2018-01-17T17:00:45-05:00
Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in 3 the immune system Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in 3 the immune system2018-01-17T17:00:45-05:00
